Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Historical Holders from Q4 2021 to Q3 2025

Symbol
LUCD on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
137,162,201
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
35,149,381
Holdings value
$35,503,868
% of all portfolios
0%
Number of holders
83
Number of buys
52
Number of sells
-21
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PAVmed Inc. 28.3% $39,205,072 38,816,903 PAVmed Inc. 09 Oct 2025
Ayrton Capital LLC 2% $1,596,645 1,200,485 Ayrton Capital LLC 31 Dec 2024

Institutional Holders of Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 35,149,381 $35,503,868 +$16,337,031 $1.01 83
2025 Q2 18,928,571 $21,732,070 +$10,810,145 $1.15 70
2025 Q1 9,361,697 $13,942,565 +$9,083,709 $1.49 47
2024 Q4 3,301,334 $2,700,118 +$681,674 $0.8187 31
2024 Q3 2,453,404 $1,999,216 +$373,764 $0.815 27
2024 Q2 1,993,582 $1,635,840 -$60,859 $0.82 31
2024 Q1 2,071,200 $1,687,992 +$173,028 $0.8099 26
2023 Q4 1,747,190 $2,463,380 -$132,319 $1.41 23
2023 Q3 1,915,159 $2,240,076 +$59,719 $1.17 23
2023 Q2 1,863,743 $2,590,935 +$131,895 $1.39 16
2023 Q1 1,768,504 $2,486,590 -$200,456 $1.4 18
2022 Q4 1,914,916 $2,603,465 -$579,811 $1.36 21
2022 Q3 2,303,350 $3,522,489 -$263,904 $1.53 20
2022 Q2 2,455,369 $5,552,000 -$914,258 $2.26 23
2022 Q1 2,705,630 $9,090,000 -$2,655,787 $3.36 30
2021 Q4 3,308,904 $17,765,000 +$14,803,000 $5.37 35